Prostaglandin E2 treatment of impotence
OwnerNathan E. Scottinventor
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions and methods for the treatment of male impotence, wherein erectile dysfunction is alleviated by administering a pharmaceutically acceptable formulation containing prostaglandin PGE.sub.2. An antidote for the effects of administration of the PGE.sub.2, or for treating priapism of other etiology, is also disclosed.
Claims19
A method of treating erectile dysfunction in a male patient, comprising the step of administering to the urethra of the patient a unit dose of a formulation comprising an erectile dysfunction treating amount of a compound having the structural formula:
- ##STR3## or pharmaceutically acceptable salt or ester thereof, together with a pharmaceutically acceptable delivery medium.
An elongated drug delivery vehicle dimensioned for transurethral insertion, said delivery vehicle containing about 2 cc of a composition comprising an erectile dysfunction treating amount of prostaglandin E.sub.2 or pharmaceutically acceptable salt thereof and a delivery medium for the transurethral delivery of said formulation, the amount of prostaglandin E.sub.2 being less than about 5.0 mg.
Dependencies are inferred from the claim text.